New Drug Approved Despite Testosterone Therapy Lawsuits
Testosterone Therapy Lawsuits
After suffering three previous denials for approval from the FDA, an injectable drug known as Aveed was approved for use in treating low testosterone in men, or “Low T”, despite present testosterone therapy lawsuits. Aveed is intended for men suffering from low testosterone due to hypogonadism. This particular therapy claims to be longer lasting, requiring an injection every few weeks instead of regular application required by gels. It also differs in that women and children cannot accidentally make contact with it, a common problem with gels.
Despite the approval of Aveed, testosterone therapy lawsuits are being filed across the U.S. based on mounting evidence of a relationship between Low T treatments and increased strokes, heart attacks, and premature death in older men with certain pre-existing heart conditions. Testosterone lawyers also note that, prior to its recent approval, Aveed was denied approval by the FDA three times based on the risks associated with testosterone therapy. Additionally, according to the website Medscape:
“The FDA is requiring that Aveed’s label contain a boxed warning regarding the risks of serious pulmonary-oil microembolism (POME) and anaphylaxis and is making the product available only through a restricted distribution scheme known as a risk evaluation and mitigation strategy (REMS) to ensure that it is used only in men for whom the benefits outweigh the risks.”
Though the treatments have been around for several years, testosterone therapy lawsuits were not filed until 2013, following a Journal of the American Medical Association (JAMA) published a study that linked these treatments with the aforementioned hazards.
The Negative Impact of Testosterone Treatments
A JAMA study found that low testosterone treatments could double the risk of heart attack in young men and those older than 65 with no prior heart conditions. The number of recipients of low testosterone treatments has multiplied by five in the past few years.
That amount of risk associated with testosterone therapy leaves a large amount of room for testosterone therapy lawsuits if more patients come forward with injuries related to testosterone treatments. Products such as testim are already the subject of scrutiny due to these implications. In the event that you or a loved one has suffered a stroke, heart attack, or death after using a Low T treatment, consider contacting the American Injury Attorney Group for a free, no obligation consultation.
Need a Testosterone Treatment Attorney?
The American Injury Attorney Group can evaluate your claim and connect you to an experienced, affiliated testosterone lawyer at no cost to you. Androgel, Axiron, Aveed, Androderm, Bio-T-Gel, Delatestryl, Depo-Testosterone, Testopel, and Testim could all potentially have increased risks associated with them. A testosterone lawyer can help you with your claim, so contact us today.